JWM
RCEL icon

JPL Wealth Management’s Avita Medical RCEL Stock Holding History

JPL Wealth Management’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19 Buy
+5
New +$21 ﹤0.01% 1537
2025
Q4 		– Sell
-5
Closed -$26 – 887
2025
Q3 		$26 Buy
+5
New +$26 ﹤0.01% 1189

Other funds holding RCEL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JPL Wealth Management's RCEL Position: Q1 2026 in Review

JPL Wealth Management opened a new position in Avita Medical (RCEL) in Q1 2026: 5 shares worth $19. The stake represents ﹤0.01% of the portfolio and ranks #1537 among its holdings. This is a return to the name: JPL Wealth Management previously reported a position in RCEL as recently as Q3 2025.

JPL Wealth Management first reported a position in RCEL in Q3 2025 and has held it in 2 quarters since. The position peaked at $26 in Q3 2025. 79 funds tracked by Wall St. Rank hold RCEL as of Q1 2026.

  • JPL Wealth Management held 5 shares of Avita Medical worth $19 as of Q1 2026.
  • Avita Medical was a new JPL Wealth Management position in Q1 2026.
  • Avita Medical made up ﹤0.01% of JPL Wealth Management's portfolio in Q1 2026, its #1537 holding.
  • JPL Wealth Management first reported a position in Avita Medical in Q3 2025 and has held it in 2 quarters since.
  • JPL Wealth Management's Avita Medical position peaked at $26 in Q3 2025.
  • 79 funds tracked by Wall St. Rank held Avita Medical as of Q1 2026.

Based on JPL Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.